Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary Thromboembolism

Condition:   Pulmonary Embolism Interventions:   Drug: Tissue Plasminogen Activator, Alteplase;   Drug: Low-molecular weight heparin Sponsor:   Ege University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials